A
Anne Rullier
Researcher at University of Bordeaux
Publications - 73
Citations - 4290
Anne Rullier is an academic researcher from University of Bordeaux. The author has contributed to research in topics: Chemoradiotherapy & Colorectal cancer. The author has an hindex of 30, co-authored 70 publications receiving 3773 citations. Previous affiliations of Anne Rullier include French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry
Paulette Bioulac-Sage,Sandra Rebouissou,Sandra Rebouissou,Cristel Thomas,Cristel Thomas,Jean-Frédéric Blanc,Jean Saric,Antonio Sa Cunha,Anne Rullier,Gaelle Cubel,Gabrielle Couchy,Gabrielle Couchy,Sandrine Imbeaud,Charles Balabaud,Jessica Zucman-Rossi,Jessica Zucman-Rossi +15 more
TL;DR: The refined HCA classification and its phenotypic correlations are refined, providing a routine test to classify hepatocellular adenomas using simple and robust immunohistochemistry.
Journal ArticleDOI
Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience
Paulette Bioulac-Sage,Hervé Laumonier,Gabrielle Couchy,Brigitte Le Bail,Antonio Sa Cunha,Anne Rullier,Christophe Laurent,Jean-Frédéric Blanc,Gaelle Cubel,Hervé Trillaud,Jessica Zucman-Rossi,Charles Balabaud,Jean Saric +12 more
TL;DR: There were noticeable clinical differences between HNF1α–inactivated HCA and IHCA; there was no increased risk of bleeding or HCC related to the number of HCAs; β‐catenin–activated HCAs are at higher risk of HCC.
Journal ArticleDOI
Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule.
Eric Rullier,Christophe Laurent,Frédéric Bretagnol,Anne Rullier,Véronique Vendrely,Frank Zerbib +5 more
TL;DR: Tumor distance from the anal verge is no longer a limit for sphincter-saving resection and the technique of intersphincteric resection permits us to achieve conservative surgery in patients with a tumor close to or in the anal canal without compromising local control and survival.
Journal ArticleDOI
Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial
Eric Rullier,Philippe Rouanet,Jean-Jacques Tuech,Alain Valverde,Bernard Lelong,Michel Rivoire,Jean-Luc Faucheron,Mehrdad Jafari,G. Portier,Bernard Meunier,Igor Sileznieff,Michel Prudhomme,Frédéric Marchal,Marc Pocard,Denis Pezet,Anne Rullier,Véronique Vendrely,Quentin Denost,Julien Asselineau,Adélaïde Doussau +19 more
TL;DR: A prospective, randomised, open-label, multicentre, phase 3 trial at 15 tertiary centres in France that were experts in the treatment of rectal cancer failed to show superiority of local excision over total mesorectal excision in patients with a good response after chemoradiotherapy.
Journal ArticleDOI
Low rectal cancer: classification and standardization of surgery.
TL;DR: This study demonstrated that most patients with low rectal cancer can receive conservative surgery without compromising oncologic outcome, and proposed a new surgical classification that should be used to standardize surgery and increase sphincter-preserving surgery in low Rectal cancer.